See more : Bionime Corporation (4737.TW) Income Statement Analysis – Financial Results
Complete financial analysis of NextFerm Technologies Ltd (NXFR.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NextFerm Technologies Ltd, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- TheWorks.co.uk plc (WRKS.L) Income Statement Analysis – Financial Results
- Datable Technology Corporation (DAC.V) Income Statement Analysis – Financial Results
- TH1NG AB (publ) (TH1NG.ST) Income Statement Analysis – Financial Results
- Welspun Living Limited (WELSPUNLIV.NS) Income Statement Analysis – Financial Results
- Dongguan Development (Holdings) Co., Ltd. (000828.SZ) Income Statement Analysis – Financial Results
NextFerm Technologies Ltd (NXFR.TA)
About NextFerm Technologies Ltd
NextFerm Technologies Ltd, a food-tech company, engages in the research, development, and marketing of yeast-based technologies and products without genetic engineering for the food industry. It offers Astaferm, a fermented-astaxanthin; NextFreeze, a yeast product to better resist multiple freeze thaw cycles; Biofuel, a novel yeast strain for more efficient production of ethanol from corn Mesh; and ProteVin, a vegan protein. The company was incorporated in 2013 and is headquartered in Yokneam Illit, Israel.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|---|
Revenue | 283.00K | 262.00K | 242.00K | 95.00K | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 979.00K | 1.38M | 219.00K | 76.00K | 498.82K | 230.10K | 158.27K |
Gross Profit | -696.00K | -1.12M | 23.00K | 19.00K | -498.82K | -230.10K | -158.27K |
Gross Profit Ratio | -245.94% | -428.24% | 9.50% | 20.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 1.99M | 4.98M | 2.81M | 2.19M | 3.08M | 2.01M | 1.75M |
General & Administrative | 1.25M | 1.36M | 1.21M | 581.00K | 636.00K | 447.00K | 362.00K |
Selling & Marketing | 514.00K | 700.00K | 506.00K | 313.00K | 302.00K | 359.00K | 107.00K |
SG&A | 1.76M | 2.06M | 1.72M | 894.00K | 938.00K | 806.00K | 469.00K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 3.69M | 6.96M | 5.44M | 3.44M | 4.60M | 2.82M | 2.22M |
Cost & Expenses | 4.67M | 8.34M | 5.66M | 3.51M | 4.60M | 2.82M | 2.22M |
Interest Income | 94.00K | 70.32K | 285.50K | 9.64K | 42.76K | 7.19K | 3.60K |
Interest Expense | 0.00 | 383.03K | 442.53K | 37.83K | 81.95K | 14.38K | 7.19K |
Depreciation & Amortization | 320.00K | 385.00K | 237.00K | 153.00K | 140.00K | 63.00K | 44.00K |
EBITDA | -4.04M | -7.72M | -4.23M | -2.90M | -3.80M | -2.75M | -2.18M |
EBITDA Ratio | -1,427.56% | -2,944.66% | -1,747.93% | -3,055.79% | 0.00% | 0.00% | 0.00% |
Operating Income | -4.36M | -8.10M | -4.47M | -3.06M | -3.94M | -2.81M | -2.22M |
Operating Income Ratio | -1,540.64% | -3,091.60% | -1,845.87% | -3,216.84% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 107.00K | 39.00K | -1.04M | -364.00K | -654.00K | -8.00K | 1.00K |
Income Before Tax | -4.25M | -8.06M | -5.51M | -3.42M | -4.60M | -2.82M | -2.22M |
Income Before Tax Ratio | -1,502.83% | -3,076.72% | -2,274.79% | -3,600.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 1.00K | 7.00K | 2.00K | 1.00K | 1.00K | 1.00K | -3.60K |
Net Income | -4.25M | -8.07M | -5.51M | -4.02M | -5.13M | -3.21M | -2.53M |
Net Income Ratio | -1,503.18% | -3,079.39% | -2,275.62% | -4,233.68% | 0.00% | 0.00% | 0.00% |
EPS | -0.06 | -0.54 | -0.49 | -1.87 | -2.85 | -1.94 | -1.67 |
EPS Diluted | -0.06 | -0.54 | -0.49 | -1.87 | -2.85 | -1.94 | -1.67 |
Weighted Avg Shares Out | 68.17M | 15.06M | 11.15M | 2.16M | 1.80M | 1.66M | 1.52M |
Weighted Avg Shares Out (Dil) | 68.17M | 15.06M | 11.15M | 2.16M | 1.80M | 1.66M | 1.52M |
Source: https://incomestatements.info
Category: Stock Reports